Hangzhou Chance Pharmaceuticals Co.
Latest round
- Series C
Last raised
- Jan 2022
Total raised
- $40M
Investors
- 8
About Hangzhou Chance Pharmaceuticals Co.
, Ltd.Founded in 2015 and headquartered in Hangzhou, China, Hangzhou Chance Pharmaceuticals specializes in biopharmaceutical development.Hangzhou Chance Pharmaceuticals is a clinical-stage biopharmaceutical firm that discovers and develops novel inhalation medications. Its advanced products include inhalation devices and formulations aimed at improving treatments for respiratory and central nervous system diseases, utilizing a proprietary virtual reality drug development platform.Hangzhou Chance Pharmaceuticals generates revenue through strategic partnerships in the biopharmaceutical sector, focusing on innovative inhalation therapies. Plans include launching additional products and expanding into international markets where respiratory and central nervous system disorders are prevalent.
Who invested in Hangzhou Chance Pharmaceuticals Co.
8 investors across 4 rounds
See all investors in Hangzhou Chance Pharmaceuticals Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hangzhou Chance Pharmaceuticals Co.
Who invested in Hangzhou Chance Pharmaceuticals Co.?
Hangzhou Chance Pharmaceuticals Co. has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Chance Pharmaceuticals Co. raised?
Hangzhou Chance Pharmaceuticals Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Hangzhou Chance Pharmaceuticals Co. last raise money?
Hangzhou Chance Pharmaceuticals Co.'s most recent round on record is a Series C, in Jan 2022.
What does Hangzhou Chance Pharmaceuticals Co. do?
Hangzhou Chance Pharmaceuticals Co. is a biotechnology company.
Where is Hangzhou Chance Pharmaceuticals Co. headquartered?
Hangzhou Chance Pharmaceuticals Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Chance Pharmaceuticals Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hangzhou Chance Pharmaceuticals Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Hangzhou Chance Pharmaceuticals Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.